These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22216677)

  • 1. Inhaled amphotericin B as fungal prophylaxis in heart transplant recipients.
    Wilde AM; Nailor MD
    Conn Med; 2011; 75(10):613-5. PubMed ID: 22216677
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients.
    Husain S; Capitano B; Corcoran T; Studer SM; Crespo M; Johnson B; Pilewski JM; Shutt K; Pakstis DL; Zhang S; Carey ME; Paterson DL; McCurry KR; Venkataramanan R
    Transplantation; 2010 Dec; 90(11):1215-9. PubMed ID: 20881664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B nebulisation for invasive pulmonary aspergillosis prophylaxis: the conflict of ideality and reality.
    Yu Y; Zhu C; Liu C; Gao Y
    Int J Antimicrob Agents; 2017 Feb; 49(2):263-264. PubMed ID: 27979501
    [No Abstract]   [Full Text] [Related]  

  • 4. Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation.
    Monforte V; Ussetti P; Gavaldà J; Bravo C; Laporta R; Len O; García-Gallo CL; Tenorio L; Solé J; Román A
    J Heart Lung Transplant; 2010 May; 29(5):523-30. PubMed ID: 20061165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant.
    Monforte V; López-Sánchez A; Zurbano F; Ussetti P; Solé A; Casals C; Cifrian J; de Pablos A; Bravo C; Román A
    J Heart Lung Transplant; 2013 Mar; 32(3):313-9. PubMed ID: 23332731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
    Kirkpatrick WR; Najvar LK; Vallor AC; Wiederhold NP; Bocanegra R; Pfeiffer J; Perkins K; Kugler AR; Sweeney TD; Patterson TF
    J Antimicrob Chemother; 2012 Apr; 67(4):970-6. PubMed ID: 22240402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
    Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolized liposomal Amphotericin B: a potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients.
    Kamalaporn H; Leung K; Nagel M; Kittanakom S; Calvieri B; Reithmeier RA; Coates AL
    Pediatr Pulmonol; 2014 Jun; 49(6):574-80. PubMed ID: 23843366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
    Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin B in three lung transplant recipients. The Groningen Lung Transplantation Group.
    Mannes GP; van der Bij W; de Boer WJ
    J Heart Lung Transplant; 1995; 14(4):781-4. PubMed ID: 7578189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary mucormycosis: benefit of aerosol amphotericin B?].
    Furco A; Mouchet B; Carbonnelle M; Vallerand H
    Rev Mal Respir; 2001 Jun; 18(3):309-13. PubMed ID: 11468594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
    Mohammad RA; Klein KC
    Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
    Solé A
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylaxis of fungal infections in haematological patients: pro].
    Glass B
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1870. PubMed ID: 20842607
    [No Abstract]   [Full Text] [Related]  

  • 15. Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
    Marra F; Partovi N; Wasan KM; Kwong EH; Ensom MH; Cassidy SM; Fradet G; Levy RD
    Ann Pharmacother; 2002 Jan; 36(1):46-51. PubMed ID: 11816256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolized Lipid Amphotericin B for Complementary Therapy and/or Secondary Prophylaxis in Patients with Invasive Pulmonary Aspergillosis: A Single-Center Experience.
    Venanzi E; Martín-Dávila P; López J; Maiz L; de la Pedrosa EG; Gioia F; Escudero R; Filigheddu E; Moreno S; Fortún J
    Mycopathologia; 2019 Apr; 184(2):239-250. PubMed ID: 30903580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid formulations of amphotericin B: clinical perspectives for the management of invasive fungal infections in children with cancer.
    Groll AH; Müller FM; Piscitelli SC; Walsh TJ
    Klin Padiatr; 1998; 210(4):264-73. PubMed ID: 9743964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive pulmonary Aspergillosis in organ transplants--Focus on lung transplants.
    Geltner C; Lass-Flörl C
    Respir Investig; 2016 Mar; 54(2):76-84. PubMed ID: 26879476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
    Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
    Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.